Skip to content
DraconiticResearch
Search Sources API
197,578 studies31 sourcesUpdated 21 min ago
Peer-reviewedCC BY 4.0Journal of Clinical Medicine

Association of Peak Circulatory Power with Invasive Hemodynamic Severity in Pulmonary Hypertension

  1. 1State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Xicheng District, Beijing 100037, China

Abstract

Background: Peak circulatory power (CP), derived from peak oxygen uptake per kilogram (peak VO2/kg) and peak systolic blood pressure (SBP), has prognostic value in cardiovascular disease, but its association with invasive hemodynamic severity in pulmonary hypertension (PH) remains unclear. We examined the relationship between peak CP and mixed venous oxygen saturation (SvO2) and other hemodynamic markers in patients with PH. Methods: This retrospective cross-sectional study included 133 adults with confirmed PH who underwent cardiopulmonary exercise testing and right heart catheterization before targeted therapy. Linear regression adjusted for age and sex evaluated associations between peak CP and SvO2, pulmonary vascular resistance (PVR), mean pulmonary arterial pressure (mPAP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and six-minute walk distance (6MWD). Exploratory receiver operating characteristic (ROC) analysis assessed the ability of peak CP to identify SvO2 ≤ 65%. Results: Median age was 33 years, and 62.4% were female. After adjustment for age and sex, lower peak CP was associated with lower SvO2 (B per 100-unit increase = 0.30, 95% CI: 0.10–0.50, p = 0.011), higher PVR (B = −0.20, 95% CI: −0.40 to −0.10, p = 0.001), higher mPAP (B = −0.70, 95% CI: −1.10 to −0.20, p = 0.003), higher NT-proBNP (B = −19.0, 95% CI: −30.9 to −7.0, p = 0.002), and shorter 6MWD (B = 2.40, 95% CI: 0.50–4.30, p = 0.015). Peak CP identified SvO2 ≤ 65% (15/133, 11.3%) with an AUC of 0.781 (95% CI: 0.674–0.888), similar to peak VO2/kg (AUC 0.783). Conclusions: In patients with PH not receiving targeted therapy, lower peak CP is age- and sex-adjusted associated with lower SvO2, higher PVR, higher mPAP, higher NT-proBNP, and shorter 6MWD, suggesting that peak CP reflects exercise cardiovascular reserve and hemodynamic severity. Thresholds and discriminatory estimates require prospective validation.

Related

  1. 4D-Flow MRI-Derived Wall Shear Stress as a Non-Invasive Biomarker for the Detection and Hemodynamic Characterization of Pulmonary Hypertension.
    Ben Statton, Chlöe Armour, Kai'en Leong +7
    Pulmonary circulationPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Comparison of Clinical, Hemodynamic and Imaging Profiles Between Isolated Pulmonary Vasculitis and Chronic Thromboembolic Pulmonary Hypertension
    Xuesheng Fang, Hanwen Zhang, Yu Chen +15
    Pulmonary circulationPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Physiology-Guided Management of Acute Right Ventricular Failure and Pulmonary Hypertension in Critically Ill Patients: Hemodynamic Phenotypes, Ventilator Interactions, and Rescue Strategies
    Akram M. Eraky, Anita J. Chazhikattu, Joseph M. Crum +1
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Pulmonary Hypertension with a High-Output Hemodynamic Profile in a Child with MELAS: A Case Report
    Miki Kanai, Hirofumi Tsuru, Takanori Onuki +7
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  5. Development and validation of novel prognostic hepatic-cardiac index and hemodynamic prediction models in pre-capillary pulmonary hypertension patients
    Jun Tong, An Wang, Chuanxue Wan +6
    Scientific ReportsPeer-reviewedCC BYFull textGeneral medicineDOAJ
BibTeX
@article{song2026association,
  title = {{Association of Peak Circulatory Power with Invasive Hemodynamic Severity in Pulmonary Hypertension}},
  author = {Ya Song and Chao Shi and Yan-Li Gu and Meng Li and Mig-Jing Zhao and Ting-Ting Dou and Liu Du and Ruo-Xi Li and Xue Feng and Xin-Xin Yan},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  month = oct,
  doi = {10.3390/jcm15218309},
  url = {https://www.mdpi.com/2077-0383/15/21/8309},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Association of Peak Circulatory Power with Invasive Hemodynamic Severity in Pulmonary Hypertension
AU  - Ya Song
AU  - Chao Shi
AU  - Yan-Li Gu
AU  - Meng Li
AU  - Mig-Jing Zhao
AU  - Ting-Ting Dou
AU  - Liu Du
AU  - Ruo-Xi Li
AU  - Xue Feng
AU  - Xin-Xin Yan
PY  - 2026
DA  - 2026/10/25
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm15218309
UR  - https://www.mdpi.com/2077-0383/15/21/8309
AB  - Background: Peak circulatory power (CP), derived from peak oxygen uptake per kilogram (peak VO2/kg) and peak systolic blood pressure (SBP), has prognostic value in cardiovascular disease, but its association with invasive hemodynamic severity in pulmonary hypertension (PH) remains unclear. We examined the relationship between peak CP and mixed venous oxygen saturation (SvO2) and other hemodynamic markers in patients with PH. Methods: This retrospective cross-sectional study included 133 adults with confirmed PH who underwent cardiopulmonary exercise testing and right heart catheterization before targeted therapy. Linear regression adjusted for age and sex evaluated associations between peak CP and SvO2, pulmonary vascular resistance (PVR), mean pulmonary arterial pressure (mPAP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and six-minute walk distance (6MWD). Exploratory receiver operating characteristic (ROC) analysis assessed the ability of peak CP to identify SvO2 ≤ 65%. Results: Median age was 33 years, and 62.4% were female. After adjustment for age and sex, lower peak CP was associated with lower SvO2 (B per 100-unit increase = 0.30, 95% CI: 0.10–0.50, p = 0.011), higher PVR (B = −0.20, 95% CI: −0.40 to −0.10, p = 0.001), higher mPAP (B = −0.70, 95% CI: −1.10 to −0.20, p = 0.003), higher NT-proBNP (B = −19.0, 95% CI: −30.9 to −7.0, p = 0.002), and shorter 6MWD (B = 2.40, 95% CI: 0.50–4.30, p = 0.015). Peak CP identified SvO2 ≤ 65% (15/133, 11.3%) with an AUC of 0.781 (95% CI: 0.674–0.888), similar to peak VO2/kg (AUC 0.783). Conclusions: In patients with PH not receiving targeted therapy, lower peak CP is age- and sex-adjusted associated with lower SvO2, higher PVR, higher mPAP, higher NT-proBNP, and shorter 6MWD, suggesting that peak CP reflects exercise cardiovascular reserve and hemodynamic severity. Thresholds and discriminatory estimates require prospective validation.
SN  - 2077-0383
ER  -